Peter Hames is Co-Founder of digital therapeutics company Big Health, an NHS Innovation Fellow, and ex-Board Chair of the global Digital Therapeutics Alliance. Big Health’s non-drug digital treatments, including Sleepio for Insomnia Disorder and Daylight for GAD, have been shown to be safe and effective across 80+ clinical publications, including 16 RCTs. Millions of people worldwide now have fully reimbursed access to Big Health therapeutics, across the US via the leading PBMs (inc CVS Health and Express Scripts), and via the NHS in the UK (Sleepio was the first fully digital treatment to receive NICE approval). Big Health has raised $130M to date, and is backed by investors including Kaiser Permanente Ventures, Octopus, Morningside, and Index Ventures. Peter holds a Master’s degree in Experimental Psychology from Oxford University.